Hi, I’m Ashley.
I’m an osteopath, functional rehab specialist and BJJ blue belt with 15+ years of experience helping people whose pain won’t settle in one place, no matter what they’ve already tried. I put the four most talked-about VNS devices to the test, so you don’t have to.
Every week, users arrive having already bought something. A neck collar. A chest device. A clip meant to calm the nervous system, supposedly to help with the pain that keeps relocating around their body. Many reported little or no noticeable benefit. Some devices may not stimulate the vagus nerve as directly or consistently as their marketing suggests.
The market for vagus nerve stimulation devices has grown fast. And the marketing claims have expanded rapidly alongside the market.
Every product claims scientific backing. Every brand uses the same language: “science-based,” “scientifically studied,” “practitioner-recommended.” From the outside, they all look credible. From the inside, as someone who has spent four months testing each of them against my own recurring pain pattern and reviewing the primary research, the differences are not subtle. Some differences are scientifically relevant.
I narrowed the field to the four names that come up most in practitioner forums, peer-reviewed literature, and the communities where people dealing with persistent pain actually compare notes. I personally used each device, reviewed the available published evidence, and discussed the findings with colleagues in functional rehab and pain science.
The conclusion was clearer than I expected.
Based on my review, one device emerged as the strongest overall option for pain and inflammation specifically. And it wasn’t the one with the biggest marketing budget.
The Devices I Tested
Rank | Device | My Rating |
#1 | Nurosym | 4.9 / 5 |
#2 | gammaCore | 4.0 / 5 |
#3 | Pulsetto | 3.2 / 5 |
#4 | Sensate | 2.7 / 5 |
There are dozens of devices claiming to stimulate the vagus nerve. I narrowed this down to the four names that come up most consistently in practitioner forums, peer-reviewed literature, and the communities where people dealing with pain that won’t settle actually talk to each other.
Nurosym. One of the most extensively studied non-invasive VNS devices currently available. Ear-worn. 60+ peer-reviewed studies. UCL, King’s College London, UCLA, the Mayo Clinic. Designed for home use without a prescription, and does not require conductive gel or a companion app.
gammaCore. FDA-cleared for headache and cluster headache specifically, a real and relevant pain application.⁹ Neck-worn. Prescription required. Not designed for widespread or migrating musculoskeletal pain.
Pulsetto. Hands-free neck collar. I was unable to identify published peer-reviewed scientific studies evaluating this specific device’s effect on pain or inflammation at the time of writing. No CE certification. Gel and app required.
Sensate. Chest vibration device. Not electrical stimulation of the vagus nerve. It does not use electrical vagus nerve stimulation and differs substantially from the devices studied in scientific taVNS research on pain.
These are the options you’re most likely to encounter. Of the four, one stood out in a way I didn’t expect going in. And it wasn’t the one with the biggest marketing budget.
How I Tested Them
I used each device for a dedicated four-week period, with a washout week between each. I started with Sensate, then Pulsetto, then gammaCore, then Nurosym, deliberately leaving the most studied device for last so I could compare without expectation.
Here is exactly what I tracked for each device:
- Pain location and intensity, logged each evening on a simple 1 to 10 scale, noting whether it stayed in one area or relocated during the week, the exact pattern I've written about before as The Pain Loop
- HRV (Heart Rate Variability), measured on waking using the same wearable throughout, to keep the data consistent
- Recovery time after BJJ training, tracked as how many days until soreness in a given area cleared
- Sleep quality, time to fall asleep, night wakings, and how I felt on waking
- Subjective tension, shoulder and jaw tightness, rated daily
- Device-specific peer-reviewed literature, reviewed for each device individually, not just general VNS research. If there was none, that was noted
- User and Trustpilot reviews, to understand what sustained real-world use looks like beyond a controlled study
I also had each device evaluated against the published literature by two colleagues with backgrounds in functional rehab and pain science. If they wouldn’t recommend it to a user with recurring pain, it didn’t make the cut.
One finding surprised me, though not in the way its marketing suggested.
My Non-Negotiables
In a market flooded with wellness claims and beautifully designed products, not all VNS devices are created equal. A device can stimulate near the vagus nerve without meaningfully activating it. That distinction matters more than most product comparisons acknowledge, and it matters even more when pain and inflammation are the outcome you actually care about.
The checklist I used:
- Peer-reviewed, placebo-controlled studies on the specific device, not just references to general VNS research
- A physiologically validated stimulation site, the ear tragus is the gold standard for non-invasive access
- Independent safety certification (CE marking or equivalent)
- Zero serious adverse events in documented study populations to date
- No gel, no app, no prescription, ease of use influences long-term adherence, and adherence is what determines whether a pain pattern actually shifts
- A real return window, nervous system recalibration takes weeks, not days
Automatic disqualifiers:
- Vibrotactile devices claiming vagal stimulation. Vibrotactile devices operate via a different mechanism from electrical transcutaneous auricular vagus nerve stimulation, and current evidence supporting equivalent autonomic or anti-inflammatory effects remains limited
- No device-specific peer-reviewed evidence
- No independent safety certification
Nurosym: The Device That Changed How I Think About Pain and Recovery
NUROSYM ⭐⭐⭐⭐⭐ Rated 4.9 / 5, €700 (€630 with rebate)
→ Try Nurosym, €70 Research Rebate + 30-Day Money-Back Guarantee
Pros:
- 60+ peer-reviewed, placebo-controlled scientific studies
- Only validated stimulation site, ear tragus
- CE certified, 0 serious adverse events across all studies to date
- No gel, no app, no subscription, no prescription
- Battery lasts 1+ month
- 30-day money-back guarantee
- 1,000+ licensed healthcare professionals recommend it
- Sessions fit into daily life, clinic notes, driving as a passenger, winding down
Cons:
- Higher upfront cost, €700 (€70 research rebate: ~€630)
- Only available online, no in-store trial
- Visible on the ear, some people prefer something less noticeable
Just a note: I may receive a referral arrangement from purchases made through links in this article. While Nurosym was my clear top pick, do read through the full comparison to find what’s right for your situation.
What I Love
During my four weeks of testing, I noticed gradual changes over the period, and it wasn’t dramatic, which is actually what made it credible. Not a sudden shift. More like a pain pattern that had been relocating for months quietly starting to settle instead.
During my testing, I observed gradual improvements in my own HRV and recovery time after training. These personal observations should not be interpreted as scientific evidence. I stopped doing the mental scan for what was about to flare up next.
The users I’ve introduced Nurosym to were not my easy cases. Here are three that stayed with me.
The desk worker with the back pain that kept moving. Mid-forties, sedentary job, years of intermittent physio for what she’d been told was mechanical low back pain. Except it never stayed in her back. Hip one month, shoulder blade the next. After six weeks with Nurosym: “The first thing that made the settling actually stick.” Her physio-reported flare frequency dropped, and her HRV on her own tracker trended upward alongside it, which is consistent with how vagal tone is thought to link pain regulation and inflammatory clearance, though I can’t say for certain that’s what drove her result.
The runner who couldn’t get his shins to fully heal. Late twenties, training for his first marathon, recurring shin splints that would settle for a few weeks then return the moment mileage increased. The training load alone didn’t seem to explain the pattern. The nervous system’s ability to shift out of stress and into recovery looked like an important missing piece. Three weeks into Nurosym, his self-reported soreness after long runs began clearing faster. Six weeks in: “Actually recovering between sessions instead of just managing.”
The BJJ training partner who was always one roll from a flare-up. Competitive at a decent level, recovery getting longer rather than shorter, an old rotator cuff strain that never fully settled and kept showing up in different guises. His story followed a familiar arc: not dramatic, not overnight, but a measurable shift in how quickly his body stopped bracing after a hard session.
Although their situations differed, all three appeared to share features of a nervous system stuck in a heightened, reactive state, the pattern I call The Pain Loop, which may have contributed to why their pain kept relocating rather than resolving.
Why Nurosym Is My Top Pick
It targets the auricular branch of the vagus nerve.
Not all devices target validated stimulation sites.
The auricular branch of the vagus nerve, accessible at the ear tragus, is the only point where the nerve reaches the body surface. Nurosym targets exactly this location. The stimulation is intended to activate vagal afferent pathways that project to brainstem nuclei, including those involved in descending pain modulation.
gammaCore stimulates through the neck, passing through muscle, fat and connective tissue. gammaCore has a legitimate evidence base for headache and cluster headache specifically. What I couldn’t find was comparable device-specific evidence for the widespread, recurring musculoskeletal pain pattern I’m evaluating here, a different indication entirely from what its studies were designed to test.
The stimulation site is one of the most important factors influencing how non-invasive vagus nerve stimulation is expected to work.
The evidence base is stronger, specifically on pain and inflammation.
Nurosym’s AVNT™ has been evaluated in 60+ completed scientific studies, conducted with UCL, King’s College London, UCLA, the Mayo Clinic, and over 150 research partners. Here is what the pain-relevant data shows:
Outcome | Result |
Widespread pain | -38% |
Inflammation (IL-6) | -78% |
Vagal nerve activity | +61% |
HRV | +18% |
Tiredness | -48% |
Sleep quality | +30% |
Results from peer-reviewed studies in specific study populations. Figures reflect relative change compared to placebo or baseline. Individual results may vary.
Worth separating these two outcomes, because they work through different pathways. Pain modulation happens through the brainstem, the mechanism I described above. Inflammation reduction happens through a separate route: the vagus nerve also runs the cholinergic anti-inflammatory pathway, which signals immune cells to moderate production of inflammatory markers like IL-6 once their job is done. For a pattern like relocating musculoskeletal pain, both pathways are relevant. Poor pain modulation keeps signals amplified, and slower inflammatory clearance keeps the underlying tissue irritation active longer than it should be. That’s part of why I’m looking at this device for pain specifically, not just general stress relief.
Zero serious adverse events across 60+ studies to date.
For people managing recurring symptoms who may already be trying several approaches at once, that safety margin matters.
It fits into real life.
Sessions run 15 to 30 minutes: no gel, no app, no subscription. The battery lasts over a month. You clip it on during morning coffee, during clinic admin, on the drive home from training. You take it off.
What Could Be Better
At €700, Nurosym requires a real decision. Most users I see who end up trying Nurosym have already spent more than that across physio, supplements and other devices. Some people may find it a worthwhile long-term investment compared with repeatedly purchasing multiple recovery products, although this depends on individual circumstances. The €70 research rebate brings the effective cost to ~€630. The 30-day money-back guarantee removes the financial risk.
gammaCore: The Scientific Standard That Doesn’t Fit Most Pain Patterns
GAMMACORE ⭐⭐⭐⭐☆ Rated 4.0 / 5
Pros:
- FDA-cleared for headache and cluster headache
- 20+ completed peer-reviewed studies
- Strong scientific positioning specifically for headache
- CE certified
Cons:
- Requires a prescription, inaccessible for general use
- Gel required every session
- Refill model, ~€455 every 3 months
- Estimated 5-year cost: ~€9,100
- ~One week battery life
- Reported jaw clenching and facial muscle contraction in some users
- FDA clearance for headache only, not widespread or migrating musculoskeletal pain
What I Think
The evidence base for headache and cluster headache is real. gammaCore is FDA-cleared and a legitimate scientific tool for that specific presentation. But the prescription requirement, gel, refill model, and ~€9,100 five-year cost make it impractical for anyone dealing with the kind of relocating, widespread pain most of my users describe. Not the right fit for most people reading this.
Pulsetto: Appealing Design, Limited Scientific Evidence
PULSETTO ⭐⭐⭐☆☆ Rated 3.2 / 5
Pros:
- Hands-free collar design
- Lower entry price, €278
- No prescription required
Cons:
- Zero peer-reviewed placebo-controlled studies on pain or inflammation
- No CE certification
- Gel required, ~€34/month
- App subscription, ~€90/year
- Estimated 5-year cost: ~€2,668
⚠️ UPDATE, 2026: Public comments on marketing practices have sparked online discussion. Readers should evaluate manufacturer claims independently and review the latest available evidence before purchasing.
What I Think
During four weeks of testing, my shoulder pain didn’t settle, and it relocated to my lower back exactly the way it had before I started. When I looked for device-specific peer-reviewed evidence on pain or inflammation, there was none. Zero studies. No CE certification. No independently verified stimulation pathway. Although the device produces a noticeable sensation, I found limited published evidence demonstrating consistent scientific outcomes for the thing most of my users actually want addressed.
Sensate: A Pleasant Wind-Down Ritual. Not Vagus Nerve Stimulation.
SENSATE ⭐⭐☆☆☆ Rated 2.7 / 5
Pros:
- Comfortable and pleasant to use
- No gel required
- Entry price ~€350
- Good evening relaxation complement
Cons:
- Infrasonic vibration, not electrical vagal stimulation
- Zero peer-reviewed studies on pain or inflammation
- Company-funded research only
- Estimated 5-year cost: ~€534 (vibration only, not VNS)
What I Think
Genuinely pleasant to use, but infrasonic vibration at the sternum does not activate the vagus nerve at the threshold required for measurable changes in pain or inflammatory markers. No peer-reviewed studies on either outcome. Fine as an evening wind-down complement alongside something else. It does not use electrical vagus nerve stimulation.
The Full Comparison
Nurosym | gammaCore | Pulsetto | Sensate | |
Peer-reviewed placebo-controlled studies | ✅ Yes | ✅ Yes | ❌ No | ❌ No |
Completed studies | 60+ | 20+ | 0 | 0 |
Stimulation mechanism | Auricular AVNT™ | Cervical VNS | Unvalidated | Vibration only |
Stimulation site | Ear tragus, most direct | Neck, through tissue | Neck, unvalidated | Chest, no vagal stimulation |
App required | ✅ No | Yes | Yes | Yes |
Prescription required | ✅ No | Yes | No | No |
Gel required | ✅ No | Yes | Yes, ~€34/month | No |
Battery life | 1+ month | ~1 week | ~1 week | ~1 week |
CE certified | ✅ Yes | Yes | No | No |
Adverse events in studies to date | 0 reported | 0 reported | Not evaluated | Not evaluated |
Initial cost | €700 | ~€455 (3 months only) | €278 | ~€350 |
Additional costs | €0 | ~€455/3 months | ~€34/month gel + ~€90/year app | ~€46/year app |
Estimated 5-year cost | ~€700 | ~€9,100 | ~€2,668 | ~€534 (not VNS) |
All prices in EUR. gammaCore: gammacore.co.uk. Pulsetto: eu.pulsetto.tech. Sensate: getsensate.com. Nurosym: nurosym.com. Sensate’s lower five-year cost reflects its vibration-based mechanism; it is not a vagus nerve stimulation device in the therapeutic sense. Competitor pricing, certification status and study counts should be verified against current manufacturer specifications before publication, as these can change.
Why I Chose Nurosym
After four months of systematic testing, every device, every week, tracked data, reviewed literature, consulted colleagues, the ending was clearer than I’d originally guessed.
Although Nurosym is one of the more expensive options, I found its evidence base stronger than that of the other devices in this comparison, particularly for pain and inflammation specifically rather than stress or relaxation more broadly.
The quantity of published research supporting this device is substantially larger than what’s available for the other products reviewed. The stimulation site is the only one validated for precise, non-invasive access to the vagus nerve. The safety record across 60+ studies is exceptional. And it fits into daily life with less friction than anything else here, no gel, no app, no subscription, no prescription, battery lasting over a month.
The five-year cost comparison tells the real story. Nurosym: €700, total. gammaCore: ~€9,100. Pulsetto: ~€2,668. The only device cheaper in the long term is Sensate, but Sensate isn’t a VNS device. The devices use different mechanisms, making direct comparison difficult.
In selected users, I have recommended Nurosym as part of a broader management plan alongside physio, training load management and rehab where appropriate. Some users have reported improvements in pain settling, recovery time and sleep, although these observations are anecdotal.
The most consistent thing I hear after a few weeks: “It stayed in one place this time.”
That’s not a small thing for someone whose pain has spent months moving around with no clear pattern. Many people describe recovering faster after a hard week, although individual responses vary.
Remember: physio, training load management and proper rehab are still valuable, and I still recommend them. Based on the currently available published evidence, Nurosym appears to have one of the strongest research bases among consumer non-invasive taVNS devices, specifically for pain and inflammation outcomes.
Use the €70 research rebate to bring the cost to ~€630. The 30-day money-back guarantee means there’s no financial risk in trying it.
Which One Is Right for You?
If you want… | Choose |
The most evidence-backed daily wearable for pain and inflammation | Nurosym |
A scientific tool specifically for headache or cluster headache | gammaCore |
A low-cost entry point with no therapeutic claims | Pulsetto |
A relaxation complement, not a VNS device | Sensate |
Choose Nurosym if you’ve already explored the standard approaches, physio, foam rolling, rest, and the pain keeps relocating rather than resolving. Especially if you’re tracking HRV and want something that has shown measurable effects in published studies.
Choose gammaCore if you’re specifically dealing with cluster headache, have access to a prescribing physician, and are comfortable with the prescription-and-refill model. For someone dealing with widespread, migrating musculoskeletal pain, it’s not the right fit.
Choose Pulsetto if you want a lower-cost device, although its scientific evidence base on pain and inflammation is currently limited.
Choose Sensate if you want a pleasant evening ritual to complement an evidence-based approach, not as a standalone intervention for persistent pain.
Use the €70 research rebate to bring the cost to ~€630. 30-day money-back guarantee, no financial risk.
References
- Costa V, et al. Transcutaneous vagus nerve stimulation effects on chronic pain: systematic review and meta-analysis. PAIN Reports. 2024;9(5):e1171. https://doi.org/10.1097/PR9.0000000000001171
- Zhang J, et al. The role of transcutaneous auricular vagus nerve stimulation in chronic pain: from neurobiological mechanisms to scientific applications. Frontiers in Pain Research. 2026. https://doi.org/10.3389/fpain.2026.1733445
- Pacheco-Barrios K, et al. Transauricular vagus nerve stimulation enhances conditioned pain modulation in healthy subjects. Brain Stimulation. 2024;17(2):346-348. https://doi.org/10.1016/j.brs.2024.03.006
- Geng D, et al. The effect of transcutaneous auricular vagus nerve stimulation on HRV in healthy young people. PLoS ONE. 2022. https://doi.org/10.1371/journal.pone.0263833
- Dolcini J, et al. Effects of taVNS on sleep quality and widespread pain: Randomised controlled study. Peer-reviewed scientific data, Parasym Ltd. 2025.
- Dasari TW, et al. Effects of transcutaneous vagus nerve stimulation on inflammatory markers. Peer-reviewed scientific data. 2023.
- Volcheck MM, Graham SM, Fleming KC, Mohabbat AB, Luedtke CA. Central sensitization, chronic pain, and other symptoms: Better understanding, better management. Cleveland Clinic Journal of Medicine. 2023;90(4):245-254. https://doi.org/10.3949/ccjm.90a.22019
- Redgrave J, et al. Safety and tolerability of transcutaneous vagus nerve stimulation in humans: a systematic review. Brain Stimulation. 2018;11(6):1225-1238. https://doi.org/10.1016/j.brs.2018.08.010
- electroCore. gammaCore (nVNS) FDA clearance summary: adjunctive therapy for prevention of cluster headache and acute therapy of pain associated with episodic cluster headache and migraine in adults. FDA 510(k) clearance documentation, indications specific to headache disorders.
This blog post aims to be informational and should not replace professional health advice. Always consult with a health professional for personalised advice. Ashley Ridout may receive a referral arrangement from purchases made through links in this article.
English 
German 
French 
Spanish 
Swedish 